In the ideal sequence of events in developing a drug, one would first select a particular disease and then proceed to learn sufficient relevant facts about it (the first difficulty); then, one would know how to predict which particular chemical structure would have the required therapeutic effects without toxicity (the second difficulty); one would then synthesize the drug (perhaps difficult but probably possible); then, one would have valid and reliable testing models of the disease in animals (not presently known for any skin disease); after proof of efficacy and safety, finally the drug would be tested in the clinic (possible). Such a sequence has never been accomplished. The etiology of inflammatory diseases, particularly, is known to a limited extent only, and the dermal manifestations of them are understood still less. The pharmacologist therefore has many good opportunities here for rewarding work.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.